Natural products for antithrombosis

C Chen, FQ Yang, Q Zhang, FQ Wang… - Evidence‐Based …, 2015 - Wiley Online Library
Thrombosis is considered to be closely related to several diseases such as atherosclerosis,
ischemic heart disease and stroke, as well as rheumatoid arthritis, hyperuricemia, and …

Tissue factor pathway inhibitor in atherosclerosis

HQ Yuan, YM Hao, Z Ren, HF Gu, FT Liu, BJ Yan… - Clinica chimica acta, 2019 - Elsevier
Tissue factor pathway inhibitor (TFPI) reduces the development of atherosclerosis by
regulating tissue factor (TF) mediated coagulation pathway. In this review, we focus on …

[HTML][HTML] CRP regulates the expression and activity of tissue factor as well as tissue factor pathway inhibitor via NF-κB and ERK 1/2 MAPK pathway

YX Chen, JF Wang, YJ Yao, WL Yuan, MY Kong… - FEBS letters, 2009 - Elsevier
It was found that C-reactive protein (CRP) could significantly enhance the activity of nuclear
factor-kappaB (NF-κB), increase the activity, antigen and mRNA expression of tissue factor …

Genome-wide linkage analysis of large multiple multigenerational families identifies novel genetic loci for coronary artery disease

Y Guo, F Wang, L Li, H Gao, S Arckacki, IZ Wang… - Scientific Reports, 2017 - nature.com
Coronary artery disease (CAD) is the leading cause of death, and genetic factors contribute
significantly to risk of CAD. This study aims to identify new CAD genetic loci through a large …

Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center …

JW Suh, SH Baek, JS Park, HJ Kang, IH Chae… - American Heart …, 2009 - Elsevier
BACKGROUND: Single nucleotide polymorphisms of vitamin K epoxide reductase complex
subunit 1 (VKORC1) was reported to have association with arterial vascular disease. We …

[HTML][HTML] Plasma tissue factor pathway inhibitor levels in angiographically defined coronary artery disease among Saudis

SS Habib - Oman Medical Journal, 2013 - ncbi.nlm.nih.gov
Objectives This study was aimed to determine plasma levels of total (TFPI-T) and free (TFPI-
F) tissue factor pathway inhibitor, plasminogen activator inhibitor-1 (PAI-1), and tissue …

[PDF][PDF] Más allá del score de calcio.

NB Guzmán-Martínez… - Anales de Radiologia …, 2019 - researchgate.net
Las enfermedades cardiovasculares (ECV) se definen como un grupo de desórdenes del
corazón y los vasos sanguíneos, tales como la cardiopatía coronaria, enfermedades …

[PDF][PDF] Studies on anticoagulant, thrombolytic and platelet aggregation inhibition properties of Leucas indica and Momordica charantia collected from Assam, India

D Gogoi - 2018 - agnee.tezu.ernet.in
Cardiovascular diseases (CVD) such as coronary heart, cerebrovascular, peripheral arterial,
rheumatic heart, myocardial infarction, and stroke are non-communicable diseases and …

[PDF][PDF] Change of tissue factor pathway ratio in Uyghur and Han patients with acute myocardial infarction in Urumqi, Xinjiang of China

R Wang, YT Ma, B Wu, P Wang, J Ma, D Chen… - Int J Clin Exp …, 2016 - e-century.us
To observe changes of tissue factor pathway (TFP) parameters and their ratios in Uyghur
and Han ethnic patients with acute myocardial infarction (AMI) in Urumqi, Xinjiang of China …

[引用][C] 冠状动脉TF/TFPI 与急性冠脉综合征关系的研究

卫任龙, 袁斌斌, 赵桂琴 - 2011